Clinical Trials Update from NCI, February 8, 2017

National Cancer Institute banner

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Clinical Trials
Updates from the National Cancer Institute
Clinical Trials News
You Tube Live Event  

Video—The Future of Prostate Cancer Research and Treatment


If you missed the broadcast in January, you can now view the recording from this YouTube Live Event. Listen in as Dr. William Dahut from NCI and Dr. Heather Cheng of the University of Washington discuss treatment options, current research, and directions for future research. 

Find Clinical Trials  

Find NCI-Supported Clinical Trials


Use our search form to find a clinical trial or other research study that may be right for you or a loved one.


New Therapy Benefits Patients with Neuroendocrine Tumors


Results from a phase III clinical trial suggest that a targeted drug that is linked to a radioactive isotope to help kill tumor cells may soon be a new treatment option for some patients with advanced neuroendocrine tumors (also known as NETs.)


Improved Survival for Some Patients with Advanced Non-Small Cell Lung Cancer


Results of a randomized clinical trial show that pembrolizumab extended the length of time patients with advanced non-small cell lung cancer lived before their disease got worse.


Less-Frequent Treatment Effective at Preventing Bone Metastasis Complications


Results of a phase III clinical trial show that people with cancer that has spread to their bones can receive less-frequent treatments of zoledronic acid to prevent bone fractures and other complications.

Clinical Trials Information for Patients and Caregivers

Informed Consent


Learn about the informed consent process and how it helps protect the rights and safety of people who take part in clinical trials.


Children’s Assent


Children cannot legally consent to take part in a trial, but they can take part in making the decision. Learn how children’s assent works.

Featured NCI-Supported Clinical Trials 

Comparison of Fast MRI and 3-D Mammograms for Women with Dense Breasts


This phase II trial studies how well FAST MRI and 3D mammography work in finding cancer in women 40 to 75 years-old with dense breasts. Combined screening with these two imaging tools may be a better method to screen women with dense breasts.


The ALCHEMIST Lung Cancer Trials


ALCHEMIST is a group of randomized clinical trials for patients with early-stage non-small cell lung cancer whose tumors have been completely removed by surgery. These trials test to see if adding targeted therapy based on tumor genetics will help prevent the cancer from returning and increase the number of people who may live longer.


Combination Therapy for Metastatic Cancer


This phase II trial is for patients with previously treated breast, head and neck, non-small cell lung, or urothelial cancer that has spread to distant parts of the body or cannot be removed by surgery. It tests how well two experimental drugs, 5-fluoro-2-deoxycytidine and tetrahydrouridine, work together.